Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1973 Sep;49(1):11–22. doi: 10.1111/j.1476-5381.1973.tb08263.x

The effects of bretylium on the subcellular distribution of noradrenaline and on adrenergic nerve function in rat heart

E T Abbs, C J Pycock
PMCID: PMC1776445  PMID: 4787519

Abstract

1. The effects of bretylium were investigated on the content and subcellular distribution of noradrenaline in the rat heart and on the response to stimulation of the sympathetic nerves supplying the heart.

2. In most experiments bretylium produced no change in the total noradrenaline content of the heart but significant changes were produced in the subcellular distribution of noradrenaline.

3. Treatment with amphetamine both prevented and antagonized the bretylium-induced adrenergic neurone blockade and most of the accompanying changes in the subcellular distribution of noradrenaline.

4. There was a temporal correlation between the bretylium-induced depletion of noradrenaline from the microsomal (P2) fraction and adrenergic neurone blockade.

5. The onset of adrenergic neurone blockade was also accompanied by an elevation of the noradrenaline content in the low-speed coarse (P1A) fraction and in the mitochondrial (P1B) fraction; this elevation was prevented by pretreatment with α-methyl-p-tyrosine.

6. It is concluded that although the elevation of the noradrenaline content of the P1A and P1B fractions and a depletion of amine from the P2 fraction are associated with the onset of adrenergic neurone blockade only the depletion from the P2 fraction is required for its maintenance. This conclusion supports the hypothesis that only a small portion of the noradrenaline content of an adrenergically-innervated organ is associated with the release of transmitter, for when this small `store' is depleted, by agents like bretylium, the nerves fail to function.

Full text

PDF
11

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbs E. T., Robertson M. I. A possible relationship between depletion of noradrenaline and blockade of adrenergic neurones. Br J Pharmacol. 1969 May;36(1):191P–192P. [PMC free article] [PubMed] [Google Scholar]
  2. Abbs E. T., Robertson M. I. Selective depletion of noradrenaline: a proposed mechanism of the adrenergic neurone-blocking action of bretylium. Br J Pharmacol. 1970 Apr;38(4):776–791. doi: 10.1111/j.1476-5381.1970.tb09887.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Abbs E. T. The release of catechol amines by choline 2,6-XYLYL ether, bretylium and guanethidine. Br J Pharmacol Chemother. 1966 Jan;26(1):162–171. doi: 10.1111/j.1476-5381.1966.tb01818.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BHAGAT B., SHIDEMAN F. E. Mechanism of the positive inotropic responses to bretylium and guanethidine. Br J Pharmacol Chemother. 1963 Feb;20:56–62. doi: 10.1111/j.1476-5381.1963.tb01296.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BURNSTOCK G., HOLMAN M. E. AN ELECTROPHYSIOLOGICAL INVESTIGATION OF THE ACTIONS OF SOME AUTONOMIC BLOCKING DRUGS ON TRANSMISSION IN THE GUINEA-PIG VAS DEFERENS. Br J Pharmacol Chemother. 1964 Dec;23:600–612. doi: 10.1111/j.1476-5381.1964.tb01613.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bhagat B., Gilliam J., Jr Effect of various procedures on the repletion of cardiac catecholamine stores after tyramine. J Pharmacol Exp Ther. 1965 Oct;150(1):41–45. [PubMed] [Google Scholar]
  7. Bhagat B. The influence of sympathetic nervous activity on cardiac catecholamine levels. J Pharmacol Exp Ther. 1967 Jul;157(1):74–80. [PubMed] [Google Scholar]
  8. CASS R., SPRIGGS T. L. Tissue amine levels and sympathetic blockade after guanethidine and bretylium. Br J Pharmacol Chemother. 1961 Dec;17:442–450. doi: 10.1111/j.1476-5381.1961.tb01131.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cession-Fossion A. Activités pharmacodynamiques comparées de la guanéthidine, de la béthanidine et du brétylium chez le rat. Arch Int Pharmacodyn Ther. 1965 Nov;158(1):45–58. [PubMed] [Google Scholar]
  10. Chang C. C., Chang J. C., Su C. Y. Studies on the interactions of guanethidine and bretylium with noradrenaline stores. Br J Pharmacol Chemother. 1967 Jun;30(2):213–223. doi: 10.1111/j.1476-5381.1967.tb02127.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Clarke D. E., Leach G. D. The influence of bretylium on the interactions of infused sympathomi- metic amines and tyramine in the reserpine-treated pithed rat. Br J Pharmacol Chemother. 1968 Feb;32(2):392–401. doi: 10.1111/j.1476-5381.1968.tb00981.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Clarke D. E. Monoamine oxidase inhibition and bretylium on adrenergic neuronal transmission. J Pharm Pharmacol. 1969 Aug;21(8):552–553. doi: 10.1111/j.2042-7158.1969.tb08314.x. [DOI] [PubMed] [Google Scholar]
  13. Dearnaley D. P., Geffen L. B. Effect of nerve stimulation on the noradrenaline content of the spleen. Proc R Soc Lond B Biol Sci. 1966 Dec 13;166(1004):303–315. doi: 10.1098/rspb.1966.0101. [DOI] [PubMed] [Google Scholar]
  14. Fillenz M., Howe P. R. The contribution of small and large vesicles to noradrenaline release. J Physiol. 1971 Jan;212(2):42P–43P. [PubMed] [Google Scholar]
  15. Gillespie J. S., Hamilton D. N., Hosie J. A. The extraneuronal uptake and localization of noradrenaline in the cat spleen and the effect on this of some drugs, of cold and of denervation. J Physiol. 1970 Mar;206(3):563–590. doi: 10.1113/jphysiol.1970.sp009031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gillespie J. S., Maclaren A., Pollock D. A method of stimulating different segments of the autonomic outflow from the spinal column to various organs in the pithed cat and rat. Br J Pharmacol. 1970 Oct;40(2):257–267. doi: 10.1111/j.1476-5381.1970.tb09919.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Hedqvist P., Stjärne L. The relative role of recapture and of de novo synthesis for the maintenance of neurotransmitter homeostasis in noradrenergic nerves. Acta Physiol Scand. 1969 Jul;76(3):270–283. doi: 10.1111/j.1748-1716.1969.tb04470.x. [DOI] [PubMed] [Google Scholar]
  18. Kopin I. J., Breese G. R., Krauss K. R., Weise V. K. Selective release of newly synthesized norepinephrine from the cat spleen during sympathetic nerve stimulation. J Pharmacol Exp Ther. 1968 Jun;161(2):271–278. [PubMed] [Google Scholar]
  19. Krauss K. R., Kopin I. J., Weise V. K. The effect of bretylium on amine retention in rat heart. J Pharmacol Exp Ther. 1970 Apr;172(2):282–288. [PubMed] [Google Scholar]
  20. LOWRY O. H., PASSONNEAU J. V., HASSELBERGER F. X., SCHULZ D. W. EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN. J Biol Chem. 1964 Jan;239:18–30. [PubMed] [Google Scholar]
  21. Malmors T., Abrams W. B. The effects of debrisoquin and bretylium on adrenergic nerves as revealed by fluorescence histochemistry. J Pharmacol Exp Ther. 1970 Jul;174(1):99–110. [PubMed] [Google Scholar]
  22. Pycock C. J., Nahorski S. R. The validity of mitochondrial marker enzymes in rat heart. J Mol Cell Cardiol. 1971 Dec;3(3):229–241. doi: 10.1016/0022-2828(71)90043-5. [DOI] [PubMed] [Google Scholar]
  23. Spriggs T. L. Peripheral noradrenaline and adrenergic transmission in the rat. Br J Pharmacol Chemother. 1966 Jan;26(1):271–281. doi: 10.1111/j.1476-5381.1966.tb01830.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES